Effect of Semaglutide 2.4 mg on Use of Antihypertensive and Lipid-lowering Treatment in STEP Trials

被引:0
|
作者
Knight, Michael
Adelborg, Kasper
Clements, Jennifer
Iversen, Aske Thorn
Laursen, Peter
Tchang, Beverly
Traina, Andrea
机构
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Poster-494
引用
收藏
页码:250 / 250
页数:1
相关论文
共 50 条
  • [41] Antihypertensive and lipid-lowering treatment to prevent heart attack (ALLHAT) trial: Interim results
    Davis, B
    Furberg, CD
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 36 (01) : 325 - 325
  • [42] COMBINED LIPID-LOWERING AND ANTIHYPERTENSIVE TREATMENT AS PART OF A STRATEGY OF MULTIPLE RISK FACTOR INTERVENTION
    MACDONALD, NJ
    FARISH, E
    STARK, S
    BARNES, JF
    ROLTON, H
    SABA, SN
    ELLIOTT, HL
    REID, JL
    JOURNAL OF HUMAN HYPERTENSION, 1991, 5 (05) : 449 - 454
  • [43] Participant recruitment in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
    Pressel, S
    Davis, BR
    Louis, GT
    Whelton, P
    Adrogue, H
    Egan, D
    Farber, M
    Payne, G
    Probstfield, J
    Ward, H
    CONTROLLED CLINICAL TRIALS, 2001, 22 (06): : 674 - 686
  • [44] Heart failure results in the antihypertensive and lipid-lowering treatment to prevent heart attack trial
    Davis, B
    EUROPEAN HEART JOURNAL, 2004, 25 : 122 - 122
  • [45] Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) - Practical implications
    Oparil, S
    HYPERTENSION, 2003, 41 (05) : 1006 - 1009
  • [46] RATIONALE FOR USE OF LIPID-LOWERING DRUGS
    DAYTON, S
    FEDERATION PROCEEDINGS, 1971, 30 (03) : 849 - &
  • [47] The use of lipid-lowering drugs in children
    Brown, W. Virgil
    Wilson, Don P.
    Freemark, Michael
    Kwiterovich, Peter O.
    JOURNAL OF CLINICAL LIPIDOLOGY, 2010, 4 (06) : 449 - 461
  • [48] Antihypertensive and lipid-lowering drugs usage after primary stroke
    Perrier, Julia
    Olie, Valerie
    Gabet, Amelie
    Pariente, Antoine
    Tzourio, Christophe
    Bezin, Julien
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 643 - 644
  • [49] Synchronizing antihypertensive and lipid-lowering therapies increases patient adherence
    Agarwal, Shuchita
    Tang, Simon
    McLaughlin, Trent
    Joyce, Amie
    Schwartz, J. Sanford
    CIRCULATION, 2006, 113 (21) : E794 - E795
  • [50] TREATMENT WITH SEMAGLUTIDE 2.4 MG LEADS TO IMPROVEMENTS IN CARDIOMETABOLIC RISK FACTORS IN THE STEP 1 TRIAL
    Kosiborod, Mikhail
    Bhatta, Meena
    Davies, Melanie
    Deanfield, John
    Garvey, Tim
    Khalid, Usman
    Kushner, Robert
    Rubino, Domenica M.
    Zeuthen, Niels
    Verma, Subodh
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 77 (18) : 1626 - 1626